NK recognition is regulated by a delicate balance between positive signals initiating their effector functions, and inhibitory signals preventing them from proceeding to cytolysis. Knowledge of the molecules responsible for positive signaling in NK cells is currently limited. We demonstrate that IL-2–activated human NK cells can express CD40 ligand (CD40L) and that recognition of CD40 on target cells can provide an activation pathway for such human NK cells. CD40-transfected P815 cells were killed by NK cell lines expressing CD40L, clones and PBLderived NK cells cultured for 18 h in the presence of IL-2, but not by CD40L-negative fresh NK cells. Cross-linking of CD40L on IL-2–activated NK cells induced redirected cytolysis of CD40-negative but Fc receptor-expressing P815 cells. The sensitivity of human TAP-deficient T2 cells could be blocked by anti-CD40 antibodies as well as by reconstitution of TAP/MHC class I expression, indicating that the CD40-dependent pathway for NK activation can be downregulated, at least in part, by MHC class I molecules on the target cells. NK cell recognition of CD40 may be important in immunoregulation as well as in immune responses against B cell malignancies.
Skip Nav Destination
Article navigation
16 June 1997
Article Contents
Article|
June 16 1997
A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction
Ennio Carbone,
Ennio Carbone
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Giuseppina Ruggiero,
Giuseppina Ruggiero
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Giuseppe Terrazzano,
Giuseppe Terrazzano
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Carmen Palomba,
Carmen Palomba
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Ciro Manzo,
Ciro Manzo
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Silvia Fontana,
Silvia Fontana
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Hergen Spits,
Hergen Spits
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Klas Kärre,
Klas Kärre
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Serafino Zappacosta
Serafino Zappacosta
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Ennio Carbone
,
Giuseppina Ruggiero
,
Giuseppe Terrazzano
,
Carmen Palomba
,
Ciro Manzo
,
Silvia Fontana
,
Hergen Spits
,
Klas Kärre
,
Serafino Zappacosta
From the *Cattedra di Immunologia, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; ‡Oncologia Sperimentale C, Immunologia, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy; §Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy; ‖Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Holland; and ¶Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden
Address correspondence to Ennio Carbone, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università di Napoli “Federico II”, Via Pansini 5, 80131, Napoli, Italy.
1 Abbreviations used in this paper: CD40L, CD40 ligand; KIR, killer cell inhibitory receptors; o.n., overnight.
Received:
December 20 1996
Revision Received:
April 14 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (12): 2053–2060.
Article history
Received:
December 20 1996
Revision Received:
April 14 1997
Citation
Ennio Carbone, Giuseppina Ruggiero, Giuseppe Terrazzano, Carmen Palomba, Ciro Manzo, Silvia Fontana, Hergen Spits, Klas Kärre, Serafino Zappacosta; A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction. J Exp Med 16 June 1997; 185 (12): 2053–2060. doi: https://doi.org/10.1084/jem.185.12.2053
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement